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Abstract We report the sequence of a human cDNA encoding a
protein homologous to devB (a bacterial gene often found in
proximity to the gene encoding glucose-6-phosphate dehydro-
genase in bacterial genomes) and to the C-terminal part of
human hexose-6-phosphate dehydrogenase. The protein was
expressed in Escherichia coli, purified and shown to be 6-
phosphogluconolactonase, the enzyme catalyzing the second step
of the pentose phosphate pathway. Sequence analysis indicates
that bacterial devB proteins, the C-terminal part of hexose-6-
phosphate dehydrogenase and yeast Sol1^4 proteins are most
likely also 6-phosphogluconolactonases and that these proteins
are related to glucosamine-6-phosphate isomerases.
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1. Introduction
The second step of the pentose phosphate pathway is the
hydrolysis of 6-phosphogluconolactone, a spontaneous reac-
tion that is greatly accelerated by a speci¢c 6-phosphogluco-
nolactonase widely distributed in the living world [1^4]. This
enzyme has been puri¢ed to homogeneity from bovine eryth-
rocytes [3] and bass liver [5] and shown to be a W30 kDa
monomer. 6-Phosphogluconolactonase hydrolyzes both the N-
and Q-forms of 6-phosphogluconolactone [3] and, in contrast
to other lactonases, does not depend on Mg2 for its activity
[2]. Until now, the sequence of this enzyme has not been
published.
Many bacterial genomes contain, in proximity to the gene
encoding glucose-6-phosphate dehydrogenase, a gene called
devB, which is homologous to the C-terminal part of the hex-
ose-6-phosphate dehydrogenase present in the endoplasmic
reticulum of mammalian cells [6,7]. These ¢ndings led us to
hypothesize that the protein encoded by devB is 6-phospho-
gluconolactonase. In this paper, we report the sequence of a
new human cDNA homologous to devB and show that it
encodes indeed a 6-phosphogluconolactonase.
2. Materials and methods
2.1. Materials
6-Phosphogluconate dehydrogenase (type V, from Torula yeast),
antipain, leupeptin and Tris were from Sigma. Glucose-6-phosphate,
glucose-6-phosphate dehydrogenase and Pwo polymerase were from
Roche. DEAE-Sepharose, Sephacryl S-200 and Thermosequenase
were from Amersham Pharmacia Biotech. IMAGE clone 329009
was ordered from HGMP (Hinxton, UK). Poly(ethyleneglycol) 6000
was from UCB. Molecular weight standards were from Bio-Rad.
2.2. Bioinformatics
ESTs homologous to the protein encoded by the devB gene of
Actinobacillus actinomycetemcomitans (D88189, [8]) were searched
with the tblastn function of the BLAST 2.0 program [9,10]. Multiple
sequence alignments were made using the PILEUP program of the
GCG package (Wisconsin Package version 10.0, Genetics Computer
Group, Madison, WI, USA).
2.3. Molecular biology techniques
The insert of clone 329009 was subcloned in pBluescript SK3 and
completely sequenced in both directions by the dideoxy method [11]
with T7 Thermosequenase and primers labelled with an infra-red dye
(IRD 41). Products were analyzed using an automated laser £uores-
cence DNA sequencer 4000L from LI-COR. cDNA prepared from
human liver RNA [12,13] with M-MLV reverse transcriptase and an
oligodT primer served as template to amplify the region correspond-
ing to the open reading frame of the devB homolog. The PCR reac-
tion was carried out with Pwo polymerase, a primer (5P-CATATG-
GCCGCGCCGGCCCCGGGCCTCA-3P) containing the ATG codon
(bold) in a NdeI restriction site (underlined) and another (5P-GC-
GGGATCCCTCTGGCCAGCTACAAAGTGG-3P) containing the
stop codon (bold) and a BamHI restriction site (underlined). The
product was cloned in pBluescript and sequenced. A NdeI-BamHI
fragment was excised from this plasmid and inserted into pET3a [14].
The chromosomal localization of the gene encoding the devB ho-
molog was determined using the low-resolution Genebridge 4 radia-
tion hybrid panel (Research Genetics). The occurrence of the human
gene encoding the devB homolog was determined by PCR with Taq
polymerase using the ¢rst primer mentioned above and a second one
corresponding to nucleotides 171^191 of the cDNA sequence. Map-
ping was computed by the RH Mapper program available on-line at
the Whitehead Institute for Genome Research, Massachussetts Insti-
tute of Technology.
2.4. Expression of the protein
BL21(DE3)pLysS cells were transformed with the expression plas-
mid and aerobically grown in M9 medium at 37‡C until an A600 of 0.6
was reached. Isopropylthiogalactoside (IPTG) was then added to a
¢nal concentration of 0.4 mM and the culture was further incubated
for 18 h at the same temperature. Bacteria were collected and extracts
were prepared as described [15], with a lysis bu¡er containing 20 mM
potassium phosphate, pH 7.4, 5 mM EDTA, 1 mM dithiothreitol,
5 Wg/ml leupeptin, 5 Wg/ml antipain, 0.5 mM PMSF and 1 mg/ml
hen egg lysozyme.
For the puri¢cation of the lactonase, an extract prepared from a 4 l
culture that was incubated for 18 h with IPTG was centrifuged for
40 min at 16 000Ug and 4‡C and 33 g of poly(ethyleneglycol) 6000
was dissolved in the resulting supernatant (200 ml). The mixture was
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maintained for 15 min on ice and centrifuged for 15 min at 12 000Ug.
The supernatant, which contained most (s 80%) of the 6-phospho-
gluconolactonase activity, was diluted 2-fold in bu¡er A (10 mM Tris,
pH 8.5, 1 mM dithiothreitol, 1 Wg/ml leupeptin and 1 Wg/ml antipain)
and applied onto a DEAE-Sepharose column (1.6U10 cm). The col-
umn was washed with 100 ml of bu¡er A and protein was eluted with
a linear gradient of NaCl (0^400 mM in 2U200 ml bu¡er A). 6-
Phosphogluconolactonase was eluted at W125 mM NaCl. The active
fractions (14 ml) were concentrated to 1.5 ml by ultra¢ltration on an
Amicon YM10 membrane and loaded onto a 1.6U50 cm Sephacryl S-
200 column, which was equilibrated and washed with a bu¡er con-
taining 20 mM HEPES, pH 7.5, 100 mM KCl, 1 mM dithiothreitol,
1 Wg/ml leupeptin and 1 Wg/ml antipain. The active fractions were
concentrated to a protein concentration of 1 mg/ml and stored at
380‡C.
2.5. Enzyme and protein assays
For the measurement of 6-phosphogluconolactonase activity, the
lactone was prepared extemporaneously by incubating 50 WM glu-
cose-6-phosphate in the presence of 0.2 mM NADP, 25 mM HEPES,
pH 7.1, 2 mM MgCl2 and 1.75 U yeast glucose-6-phosphate dehydro-
genase in 1 ml at 30‡C. When the A340 reached a plateau, 0.5 U/ml 6-
phosphogluconate dehydrogenase and the preparation of lactonase to
be assayed (between 0.5 and 5 mU) were added and A340 was further
measured for about 10 min. The blank corresponding to the sponta-
neous hydrolysis of lactone (W0.8 nmol/min/ml) was subtracted. One
unit of enzyme is the amount that hydrolyzes 1 Wmol of 6-phospho-
gluconolactone per min under these conditions. Protein was measured
according to Bradford [16] with bovine Q-globulin as a standard.
3. Results and discussion
3.1. Identi¢cation and sequence of a human cDNA encoding a
devB homolog
A BLAST search in human EST databanks for homologs of
devB from A. actinomycetemcomitans yielded about 80 se-
quences, which all appeared to be derived from one single
gene, di¡erent from the one encoding human hexose-6-phos-
phate dehydrogenase [7]. Further BLAST searches with these
sequences allowed us to identify a total of about 100 human
ESTs derived from this gene. The clone with the most 5P
sequence was subcloned and completely re-sequenced on
both strands. We also independently sequenced the region
corresponding to the open reading frame, which was PCR-
ampli¢ed from human liver cDNA.
The cDNA sequence derived from these results is shown in
Fig. 1. The ¢rst ATG codon is in an appropriate Kozak con-
sensus sequence [17] and is conserved in the mouse cDNA, the
sequence of which could be reconstituted from ESTs (not
shown). In the human sequence, the initiator codon opens a
reading frame predicting a protein of 258 residues, with a
calculated molecular mass of 27 529.
Compared to the sequence derived from the product ampli-
¢ed from liver cDNA, clone 329009 presented a 20 bp deletion
(Fig. 1). This deletion was only observed in two amongst the
70 human or mouse ESTs that are informative for this region
of the sequence. Remarkably, the two ESTs presenting this
deletion (W43017 and W43013) are derived from the same
cDNA bank (from human pancreatic islet) as clone 329009.
This suggests that this deletion, which changes the reading
frame and therefore modi¢es the last 54 residues of the pro-
tein, is due to a genomic mutation present in the subject from
whom the RNA was isolated to construct the library. As often
Fig. 1. Sequence of the cDNA encoding the human homolog of
devB (human 6-phosphogluconolactonase). The stop codon is under-
lined and the nucleotides missing in clone 329009 are italicized.
Fig. 2. Puri¢cation of 6-phosphogluconolactonase on Sephacryl S-
200. Fractions from the DEAE-Sepharose column were pooled, con-
centrated and applied onto a Sephacryl S-200 column. Fractions of
1 ml were collected. 6-Phosphogluconolactonase activity and the
protein concentration are shown in (A). The indicated fractions
were analyzed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and Coomassie blue staining (B).
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[18], this deletion occurs between two short direct repeats,
GAAG in the present case.
3.2. Chromosomal localization
Using a radiation hybrid panel, we mapped the gene encod-
ing the human devB homolog between markers WI-6344 and
WI-1413 to 19p13.2.
3.3. Expression and characterization of the encoded protein
The open reading frame was inserted in pET3a, which was
used to express the encoded protein in Escherichia coli
BL21(DE3)pLysS [14]. Extracts were prepared from bacteria
di¡erent times after induction with IPTG and the 6-phospho-
gluconolactonase activity was measured in supernatants. This
activity, which was below the detection limit of our assay
(0.02 U/mg protein) before the induction, reached a value of
about 10^15 U/mg protein after 18 h at 37‡C. No lactonase
activity was detected when the bacteria contained a pET plas-
mid without insert.
The recombinant lactonase was puri¢ed about 50-fold with
a W20% yield by a procedure involving (1) elimination of
about 80% of the protein by precipitation with 16.5% poly-
(ethyleneglycol) 6000, (2) anion-exchange chromatography on
DEAE-Sepharose and (3) gel ¢ltration on Sephacryl S-200. In
the last step (Fig. 2), the lactonase co-eluted with a polypep-
tide of the expected size (W30 kDa). The two other proteins
that were still present in the preparation had an elution pro¢le
that did not match that of the activity. The speci¢c activity of
the purest fraction (710 U/mg protein) was intermediary be-
tween the values reported for the enzymes puri¢ed to homo-
geneity from bovine erythrocytes (W55 U/mg protein, [3]) and
from bass liver (W8300 U/mg protein, [5]). These di¡erences
could be due to the use of di¡erent assay conditions.
Comparison of the elution volume of recombinant 6-phos-
phogluconolactonase with those of molecular weight stand-
ards run on the same column allowed us to calculate a mo-
lecular mass of 30 kDa, indicating a monomeric structure, in
agreement with previous results [3,5].
3.4. Sequence comparisons
BLAST searches performed with the human lactonase
showed that the closest homologs to this enzyme were the
yeast Sol1^4 proteins (33^37% sequence identity) followed
by the C-terminal part of human hexose-6-phosphate dehy-
drogenase (26% identity), bacterial devB proteins (20^25%
identity) and glucosamine-6-phosphate isomerases (17% iden-
tity in the case of the human enzyme). An alignment of some
of these proteins with human 6-phosphogluconolactonase is
shown in Fig. 3.
Glucosamine-6-phosphate isomerase catalyzes the conver-
sion of glucosamine-6-phosphate and H2O to fructose-6-phos-
phate and NH3. One of its substrates (H2O) is therefore
shared with 6-phosphogluconolactonase and the other is sim-
ilar in structure between C-3 and C-6 with 6-phosphogluco-
nolactone. However, puri¢ed recombinant 6-phosphoglucono-
lactonase was unable to deaminate glucosamine-6-phosphate,
no production of fructose-6-phosphate (6 0.2 Wmol/min/mg
protein) being observed in the presence of 1 mM glucos-
amine-6-phosphate, with or without 0.1 mM N-acetylglucos-
amine-6-phosphate, an allosteric e¡ector of the isomerase [19].
Fig. 3. Alignment of the sequence of human 6-phosphogluconolactonase with Sol1 from Saccharomyces cerevisiae, with devB from A. actinomy-
cetemcomitans, with the C-terminal part of human hexose-6-phosphate dehydrogenase and with glucosamine-6-phosphate isomerases from hu-
man and from E. coli. The residues in bold are those that are strictly conserved either amongst 6-phosphogluconolactonases (the human en-
zyme and the devB genes found in proximity to the genes encoding glucose-6-phosphate dehydrogenase or 6-phosphogluconate dehydrogenase
in the genomes of A. actinomycetemcomitans, Chlamydia trachomatis, Helicobacter pylori, Mycobacterium tuberculosis, Mycobacterium leprae,
Neisseria gonorrhoeae and Treponema pallidum) or amongst glucosamine-6-phosphate isomerases (i.e. the human and E. coli enzymes as well as
the homologs found in nag operons in the genomes of Bacillus subtilis, Borrelia burgdorferi, Clostridium acetobutylicum and Haemophilus in£u-
enzae). The underlined residues were concluded to interact with the substrate of glucosamine-6-phosphate isomerase based on the crystal struc-
ture of this enzyme [23].
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Since two enzymes catalyzing di¡erent reactions appeared
to be homologous, it was of interest to identify the residues
speci¢cally involved in both functions. To identify these resi-
dues in the 6-phosphogluconolactonases, we restricted our
analysis to (1) human 6-phosphogluconolactonase and (2)
the bacterial devB proteins that are encoded by operons
also containing the glucose-6-phosphate dehydrogenase gene.
In the absence of experimental proof that the bacterial devB
proteins are 6-phosphogluconolactonases (one of them, from
Pseudomonas aeruginosa, is mentioned as 6-phosphoglucono-
lactonase in the databanks under accession number AF029673
but without any reference to published work), this proximity
is good evidence for this catalytic function. Similarly, identi-
¢cation of strictly conserved residues in glucosamine-6-phos-
phate isomerases was obtained by comparing the sequence of
the enzymes from Homo sapiens and E. coli with bacterial
homologs present in nag (N-acetylglucosamine) operons.
The strictly conserved residues in each type of enzyme (Fig.
3) are more abundant in the isomerase than in the lactonase
(56 versus 15), indicating that the former enzyme is more
conserved than the latter. This may be because glucosamine-
6-phosphate isomerase, which forms hexamers [20] and is al-
losterically regulated [19], is more constrained than 6-phos-
phogluconolactonase, a monomeric enzyme without known
allosteric regulation [21]. Out of these strictly conserved resi-
dues, eight are common between both enzymes. Analysis of
the crystal structure of E. coli glucosamine-6-phosphate iso-
merase bound to a substrate analog [23] has led to the con-
clusion that three of these eight residues (underlined in Fig. 3)
interact with glucosamine-6-phosphate: D72 with the hydro-
gen bound to C-2 and an oxygen bound to C-1, H143 with the
oxygen bound to C-5 and K208 with the phosphate group. In
addition, residues 41^44, which comprise a strictly conserved
glycine residue, form a loop that hydrogen-bonds with the
phosphate group [22]. The residues in equivalent positions
in 6-phosphogluconolactonase most likely interact in a similar
fashion with 6-phosphogluconolactone.
Further comparisons indicate that R81, F159 and R185
(positions indicated for the human 6-phosphogluconolacto-
nase) are a ‘signature’ for the lactonase. R81 replaces a tyro-
sine (Y74 in the E. coli isomerase) close to the conserved
aspartate (D72) mentioned earlier. We speculate that R81
stabilizes the anion that forms during hydrolysis of the lac-
tone.
Since the yeast Sol1^4 proteins share the lactonase-speci¢c
residues (except for a glycine which is replaced by an alanine
in Sol1 and Sol2) and are actually even closer to human 6-
phosphogluconolactonase than the bacterial devB proteins, it
is likely that they also catalyze the hydrolysis of 6-phospho-
gluconolactone. However, it is not obvious how this lactonase
activity can account for the function of Sol1 to act as a multi-
copy suppressor of the los1-1 mutation, which prevents yeast
from correctly splicing a suppressor tRNA [23]. The sequence
comparisons (Fig. 3) also suggest that mammalian hexose-6-
phosphate dehydrogenase is a bifunctional enzyme catalyzing
the ¢rst two steps of the pentose phosphate pathway in the
endoplasmic reticulum. By contrast, these two reactions are
catalyzed by separate enzymes in the cytosol, the lactonase
being the one characterized in the present work.
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